ARIAD to Present at Bank of America Merrill Lynch 2012 Health Care
CAMBRIDGE, Mass. -- May 10, 2012
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
webcast its presentation at the Bank of America Merrill Lynch 2012 Health Care
Conference in Las Vegas. Harvey J. Berger, M.D., chairman and chief executive
officer, will provide an overview of the Company’s business on Wednesday, May
16, 2012 at 9:20 a.m. (PT).
The ARIAD presentation at the Bank of America Merrill Lynch 2012 Health Care
Conference will be webcast live and can be accessed by visiting the investor
relations section of the Company's website at http://www.ariad.com/investor. A
replay of the webcast presentation will also be available and archived on the
site for three weeks.
ARIAD Pharmaceuticals, Inc. is an emerging global oncology company focused on
the discovery, development and commercialization of medicines to transform the
lives of cancer patients. ARIAD’s approach to structure-based drug design has
led to three internally discovered, molecularly targeted product candidates
for drug-resistant or difficult-to-treat cancers, including certain forms of
chronic myeloid leukemia, soft tissue and bone sarcomas and non-small cell
lung cancer. For additional information, visit http://www.ariad.com or follow
ARIAD on Twitter.
ARIAD Pharmaceuticals, Inc.
Maria E. Cantor, 617-621-2208
Lynn Granito, 212-253-8881
Press spacebar to pause and continue. Press esc to stop.